• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES LLC EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES LLC EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750TFX26A
Device Problem Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/27/2023
Event Type  malfunction  
Event Description
As reported by the field clinical specialist, during a right transfemoral tavr procedure, the 26 mm sapien 3 ultra valve became stuck in the 14f esheath upon insertion of valve and 26 mm commander delivery system.Multiple attempts were made to advance the valve through the esheath.The physician requested a new valve and 16f esheath, and the procedure was completed successfully with no patient complications.Upon the removal of 14f esheath and delivery system, it was noted that valve was stuck on the side wall of the esheath.However, they were unable to determine if there was frame damage because valve remained inside the sheath.The engineering evaluation of the returned devices revealed a sheath shaft puncture approximately 1.5 inches from the strain relief caused by a valve strut.It was found that the valve struts were bent.
 
Manufacturer Narrative
Investigation is ongoing.
 
Manufacturer Narrative
A supplemental is being submitted for the completed engineering evaluation.Sections b.2, b.4, g.3, g.6, h.2, and h.3 have been updated.Corrections have been made to h.6: type of investigation, investigation finding, and investigation conclusion, and impact code.An additional code was added to h.6: component code.The event reported is anticipated in the risk management documentation for transcatheter heart valve procedures.A previous investigation into this type of event is captured in an edwards lifesciences technical summary and applies to this complaint.Additional assessment of the failure mode is not required at this time.Per the technical summary, the instructions for use (ifu), current risk mitigations include design and manufacturing controls, and training manuals have been reviewed, no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.The device was returned for evaluation.The returned device was visually examined for any abnormalities and the following was observed: the crimped valve was exposed through the sheath, one strut was bent at the inflow side, multiple struts were exposed through the skirt which was normal after excessive manipulation during the insertion, the frame was distorted, and the leaflets were wrinkled and dehydrated due to the storage conditions (prolonged crimping) during the return handling process.Due to the nature of the complaint, no applicable dimensional or functional testing was performed.The complaint for frame damage was confirmed based on visual examination of the device returned.As reported, there was difficulty advancing the delivery system through the sheath, resulting in difficulty or the inability to introduce the delivery system and advance through the sheath, prolonging the procedure.Available information suggests procedural factors (excessive manipulation/high push force) likely contributed to the event as the strut was bent outward at the inflow side.Excessive device manipulation or high push force can lead to the valve struts interacting with the sheath shaft and result in the strut damage at the valve inflow side.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Since no edwards product defects or labeling deficiencies were identified, no corrective or preventative action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18499509
MDR Text Key333113295
Report Number2015691-2024-00311
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103201338
UDI-Public(01)00690103201338(17)260807
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750TFX26A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/12/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/18/2023
Initial Date FDA Received01/11/2024
Supplement Dates Manufacturer Received03/27/2024
Supplement Dates FDA Received04/01/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/08/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-